June 13, 2025- Premier submitted a statement for a June 11, 2025 House Energy and Commerce Health Subcommittee hearing entitled “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.” In its statement, Premier underscored that securing our nation’s healthcare supply chain has been a long-standing priority for Premier from both a policy perspective and market-based approach. As the subcommittee considers policy reforms to address critical healthcare supply chain issues, Premier urged the Subcommittee to consider:
- Leveraging tax credits as a mechanism to incentivize manufacturers to invest in domestic production while also ensuring that domestically manufactured goods are price competitive with globally sourced products.
- Taking action to strengthen domestic manufacturing of essential medicines by:
- Requiring federal agencies to purchase domestically manufactured medical supplies when available;
- Providing CMS with statutory authority to implement payment adjustments for domestically manufactured critical medical supplies and pharmaceuticals in a non-budget neutral manner; and
- Adapting the Food and Drug Administration (FDA) regulatory framework for approval to expedite review of applications and inspections of manufacturing facilities for new domestic entrants.
- Passing the bipartisan and bicameral Medical Supply Chain Resiliency Act (S. 998/H.R. 2213) to establish trade agreements with trusted trade partner countries to diversify sourcing for critical medical devices and pharmaceuticals, protect public health and bolster national security.